Effects of vancomycin linoleic acid nanoparticles on male reproductive indices of Sprague–Dawley rats
Source abstract
Abstract
The management of bacterial infections, especially trains of methicillin-resistant Staphylococcus aureus observe in health care settings, has markedly improved with the introduction of established drugs but using newer nano-based formulations. This study investigates the effects of vancomycin-linoleic acid nanoparticles on testicular tissue in an experimental animal model. Twenty-five adult male Sprague–Dawley rats maintained at the Animal House of the Biomedical Resources Unit were assigned to five groups namely E – solid lipid nanoparticles; F – vancomycin solid lipid nanoparticle; G – linoleic acid nanoparticle; H – vancomycin linoleic acid; and A – control. Perturbations in seminal fluid parameters showed a reduced sperm count in groups F & G which was statistically significant (p < .05) but motility and morphology were not significant when compared to controls (A). Reduced testosterone levels were found in groups E, F and H but were not statistically significant (p > .05). There was also increased luteinizing hormone (LH) and decreased in follicular stimulating hormone (FSH) levels was statistically significant (p < .05). Hypoplasia, tubular atrophy and shrinkage were observed in histologic sections of the treated groups with basement membrane thickening. Vancomycin solid lipid nanoparticle and its constituents SLN and LA disrupted testicular morphometry and the hormonal milieu sufficient to potentially induce altered reproductive function.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Sperm and Testicular Function · Reproductive System and Pregnancy · Immune Response and Inflammation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Discipline of Clinical Anatomy, Nelson R. Mandela School of Medicine, University of Kwazulu-Natal, Durban, South Africa
Department of Anatomy, School of Medicine, University of Namibia, Windhoek, Namibia
Funding
National Research Foundation of South Africa · CHS-UKZN Nano-mobility grant · Dr S. D. Singh and Dr L. Bester of the Biomedical Research Unit, University of KwaZulu-Natal
References (55)
Show source-provided references
1. Lederberg J, Davis JR. Emerging infectious diseases from the global to the local perspective: workshop summary. New York (NY): National Academies Press; 2001.
2. 10.3389/fpubh.2014.0014510.3389/fpubh.2014.00145 ↗
3. Ferraz V, Duse A, Kassel M, et al. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S Afr Med J. 2000;90(11):1113.
4. Okeke IN, Sosa A. Antibiotic resistance in Africa-discerning the enemy and plotting a defence. Africa Health. 2003;25:10–15.
5. 10.1080/10408398.2015.107719210.1080/10408398.2015.1077192 ↗
6. 10.1016/S0140-6736(12)60560-110.1016/S0140-6736(12)60560-1 ↗
7. 10.1183/09031936.0018831310.1183/09031936.00188313 ↗
8. 10.1186/s13756-017-0208-x10.1186/s13756-017-0208-x ↗
9. 10.1016/j.colsurfb.2015.10.00310.1016/j.colsurfb.2015.10.003 ↗
10. 10.1080/22221751.2020.176950010.1080/22221751.2020.1769500 ↗
11. McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–281.
12. 10.1007/s11010-020-03833-410.1007/s11010-020-03833-4 ↗
13. 10.1016/B978-0-323-39307-2.00033-310.1016/B978-0-323-39307-2.00033-3 ↗
14. 10.1097/JOM.0b013e31821ad5c010.1097/JOM.0b013e31821ad5c0 ↗
15. 10.1016/j.colsurfb.2014.02.04510.1016/j.colsurfb.2014.02.045 ↗
16. 10.1002/prp2.77610.1002/prp2.776 ↗
17. 10.1016/j.jece.2020.10405410.1016/j.jece.2020.104054 ↗
18. 10.1166/jnn.2015.1169110.1166/jnn.2015.11691 ↗
19. 10.1007/s13205-018-1286-z10.1007/s13205-018-1286-z ↗
20. 10.1002/fsn3.171210.1002/fsn3.1712 ↗
21. 10.1039/D0TB90139C10.1039/D0TB90139C ↗
22. 10.1016/j.theriogenology.2020.12.00610.1016/j.theriogenology.2020.12.006 ↗
23. 10.1016/j.tibtech.2008.04.00510.1016/j.tibtech.2008.04.005 ↗
24. 10.1038/nnano.2007.22310.1038/nnano.2007.223 ↗
25. 10.1016/j.shaw.2013.07.00610.1016/j.shaw.2013.07.006 ↗
26. 10.1002/1520-6017(200010)89:10<1243::AID-JPS2>3.0.CO;2-C10.1002/1520-6017(200010)89:10<1243::AID-JPS2>3.0.CO;2-C ↗
27. 10.3390/ph1306011010.3390/ph13060110 ↗
28. 10.1016/j.msec.2015.12.05310.1016/j.msec.2015.12.053 ↗
29. Organisation WHO. WHO laboratory manual for the examination and processing of human semen. Switzerland: WHO Press; 2010.
30. 10.5487/TR.2016.32.4.31710.5487/TR.2016.32.4.317 ↗
31. 10.1111/and.1264010.1111/and.12640 ↗
32. 10.1080/0192623029010572110.1080/01926230290105721 ↗
33. 10.1111/j.1365-2818.1987.tb02837.x10.1111/j.1365-2818.1987.tb02837.x ↗
34. 10.1093/biolreprod/22.2.38310.1093/biolreprod/22.2.383 ↗
35. 10.1086/49170910.1086/491709 ↗
36. 10.1016/j.fertnstert.2014.09.01610.1016/j.fertnstert.2014.09.016 ↗
37. 10.1093/humrep/dev05810.1093/humrep/dev058 ↗
38. 10.1093/oxfordjournals.humrep.a13701810.1093/oxfordjournals.humrep.a137018 ↗
39. 10.1002/j.1939-4640.2000.tb03284.x10.1002/j.1939-4640.2000.tb03284.x ↗
40. 10.1186/s12958-015-0032-110.1186/s12958-015-0032-1 ↗
41. 10.2174/187446720866615012615503210.2174/1874467208666150126155032 ↗
42. 10.1007/978-3-319-19791-3_210.1007/978-3-319-19791-3_2 ↗
43. 10.1111/j.1464-410X.2007.07406.x10.1111/j.1464-410X.2007.07406.x ↗
44. 10.1007/s10815-013-0078-y10.1007/s10815-013-0078-y ↗
45. 10.4149/BLL_2015_06010.4149/BLL_2015_060 ↗
46. 10.2147/IJN.S11144710.2147/IJN.S111447 ↗
47. 10.1016/j.clinthera.2007.06.01410.1016/j.clinthera.2007.06.014 ↗
48. 10.1128/AAC.01602-0710.1128/AAC.01602-07 ↗
49. 10.1128/AAC.01088-0810.1128/AAC.01088-08 ↗
50. 10.1111/j.1464-410X.2011.10783.x10.1111/j.1464-410X.2011.10783.x ↗
51. 10.1590/S1807-5932201100040002610.1590/S1807-59322011000400026 ↗
52. Aprioku JS. Pharmacology of free radicals and the impact of reactive oxygen species on the testis. J Reprod Infertil. 2013;14(4):158–172.
53. 10.2164/jandrol.108.00513210.2164/jandrol.108.005132 ↗
54. 10.1097/WOX.0b013e318243961310.1097/WOX.0b013e3182439613 ↗
55. 10.1016/B978-012369413-3/50078-110.1016/B978-012369413-3/50078-1 ↗